Home Newsfeeds Maxim Group Initiates Coverage On Aclarion with Buy Rating, Announces Price Target of $3

Maxim Group Initiates Coverage On Aclarion with Buy Rating, Announces Price Target of $3

Maxim Group analyst Anthony Vendetti initiates coverage on Aclarion (NASDAQ:ACON) with a Buy rating and announces Price Target of $3.

July 6, 2022

1 minute read

Maxim Group analyst Anthony Vendetti initiates coverage on Aclarion (NASDAQ:ACON) with a Buy rating and announces Price Target of $3.

Expert Ratings for C4 Therapeutics

May 8, 10:01 AM

Within the last quarter, C4 Therapeutics (NASDAQ:CCCC) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

November 18, 4:12 PM

Block Inc (NASDAQ: SQ) are down 59.8% year-to-date in 2022 amid crypto winter, and short sellers have made a killing betting against the stock.

August 18, 8:15 AM

Wedbush analyst Seth Basham downgrades Bed Bath & Beyond (NASDAQ:BBBY) from Neutral to Underperform and announces $5 price target.

November 29, 5:00 PM

Microchip Technology (NASDAQ:MCHP) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…